Skip to main content
Jinyin Li on Muck Rack

Jinyin Li

As seen in: Frontiers, MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jinyin

Contact Jinyin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Sintilimab-induced delayed-onset toxic epidermal necrolysis in a patient with gastric carcinoma: a case report and literature review

|
By Shilong Mao, Liming Wang, Xiaoyan Yang, Rongrong Zhang, Li Chen, Ling Jiang, Jinyin Li, Yiping Gao, Zi Ye, Qiaoqiao Cheng
| Frontiers
Abstract Background: Sintilimab, a programmed death-1 (PD-1) inhibitor widely used in various malignancies, has demonstrated favorable antitumor efficacy and safety. However, severe immune-related cutaneous adverse events (irCAEs) such as toxic epidermal necrolysis (TEN) are rare but potentially fatal. Understanding their clinical characteristics, treatment strategies, and pathophysiological mechanisms is crucial for optimal management.
Open in Who Shared Issue with article?

Catalysts | Free Full-Text | Development of a γ-Al2O3-Based Heterogeneous Fenton-like Catalyst and Its Application in the Advanced Treatment of Maotai-Flavored Baijiu Wastewater

|
By Yujing Yan, Fei Guo, Benfu Luo, Jinyin Li
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared View Duplicates (103) Issue with article?
See all 2 articles